BSEBoard Meeting3d ago · 10 Aug 2026, 10:27 pm

Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve quarterly financial result ....

Integrated Proteins Ltd · 519606

✦ AI SummaryResults

Integrated Proteins Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve quarterly financial results for the quarter ended on June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Integrated Proteins Ltd - 519606 - Board Meeting Intimation for Board Meeting Intimation For Intimation For Board Meeting Pursuant To Regulation 29 Of The SEBI(LODR) Regulation, 2015

Attachments (1)

📄

f5a2fcf8-a73c-4e65-9e26-891fd5fc3bf1.pdf

pdf

Download →
View document text
INTEGRATED PROTEINS LIMITED Manek Centre,Of(cid:976)ice No 218,P N Marg,Jamnagar – 361008, Gujarat,India Phone:9428817400 Email ID: integrated.pl2024@gmail.com Website: www.integratedproteins.com CIN: L62013GJ1992PLC018426 Date: August 10, 2026 Department of Corporate Service BSE Limited Phiroz Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip code: 519606 Sub: In(cid:415)ma(cid:415)on of Board Mee(cid:415)ng Dear Sir/Madam, This is to inform you under Regula(cid:415)on 29 and any other Regula(cid:415)on of SEBI (Lis(cid:415)ng Obliga(cid:415)ons and Disclosure Requirements) Regula(cid:415)ons, 2015 that a Mee(cid:415)ng of the Board of Directors of the Company will be held on Friday, August 14, 2026 at the Registered Office of the Company situated at Office no. 218 ,Manek Centre, Pandit Nehru Marg, Patel Colony, Jamnagar, 361008 Gujarat, to transact the following business; 1. To Consider and Approve unaudited Financial Results of the Company for the Quarter ended on June 30, 2026 along with Limited Review Report for the said period as per Regula(cid:415)on 33 of SEBI (Lis(cid:415)ng Obliga(cid:415)ons and Disclosure Requirements) Regula(cid:415)ons, 2015 . 2. Any other item with the permission of the Chair and Majority of Directors. Further, in terms of SEBI (Prohibi(cid:415)on of Insider Trading) Regula(cid:415)ons, 2015 as amended by SEBI (Prohibi(cid:415)on of Insider Trading) (Amendment) Regula(cid:415)ons, 2018 and in accordance with Company’s Code of Conduct for Preven(cid:415)on of Insider Trading, the trading window was closed from Wednesday, 1st July, 2026 which shall open a(cid:332)er 48 hours of declara(cid:415)on of Results/submission of outcome in view of the aforesaid Board Mee(cid:415)ng. Please take the same on your record. Yours Faithfully, Hiren Dhirajlal Shah Chairman and Managing Director DIN: 09842161